A Biopharmaceutical Company’s Journey to Savings and Optimized Sample Management
App Note / Case Study
Published: January 6, 2025
Credit: Azenta
For large companies that operate across many sites, streamlining sample storage and management poses many unique challenges. In this case study, a top global biopharmaceutical company needed to improve compliance, gain visibility and enhance efficiency in the management of their clinical and research samples.
Learn how this client partnered with Azenta Life Sciences to integrate industry-leading sample capabilities and enterprise-wide sample exploration and management solutions to improve operations and accelerate therapeutic discovery, development and delivery.
Download this case study to discover how to:
- Create a centralized inventory
- Improve traceability for regulatory compliance
- Reduce procurement efforts and storage costs
azenta.com
Sample Management and Automation
A Biopharmaceutical Company’s
Journey to Savings and Optimized
Sample Management through
Partnership with Azenta
CASE STUDYSample Management and Automation | Case Study
Azenta Life Sciences 2
The Challenge
A top global biopharmaceutical company providing
life-changing treatments in areas like oncology,
immunology, and neurology needed to improve
compliance, gain visibility, and enhance efficiency in
the management of their clinical and research samples.
Multiple factors converged that required action:
• Clinical samples were being managed by a central lab
partner that had supported their clinical trials. Access
to these samples was limited and the cost for longterm storage was escalating.
• There was a fragmented approach to management
of samples across the departments with multiple
inventory systems in use, limited access to tracking
information, and inconsistent terminology.
• The company was undergoing a transformation within
its research and development (R&D) structure. As
part of this restructure, scientists spread across 8
sites in one region would be moved into a single R&D
hub to maximize collaboration and scientific output.
Across these 8 sites there were approximately 1,400
storage units and a large portion of non-centralized
inventories.
While the immediate issue that needed to be addressed
was consolidating the 8 R&D sites, they also had a
total of 21 R&D facilities across the globe with similar
challenges.
The organization was charged
with addressing:
Catalog
R&D groups across
mixed samples
reduction of
Create a centralized inventory for
cold storage units in less than a year
mixed samples
14
1M+
43%
8 sites
1375
2M+Sample Management and Automation | Case Study
Azenta Life Sciences 3
The Solution
To choose the right partner, the biopharmaceutical company examined the most critical attributes for success from
both quantitative and qualitative perspectives. For them, it was not just important to solve their challenges, but to
ensure a solution that would be scalable and ultimately improved by working with the right partner.
Experience – Is there a clear understanding of project and budget requirements? Can we rely on this partner’s
business development and support teams to be responsive and flexible?
Planning – Are we future-proofing our strategy to meet the needs of tomorrow? Is there a master service
agreement (MSA) and durable documentation in place?
Capabilities – Can our partner handle all aspects of project logistics; both high volume processing and
shipping of 1000 samples per day, as well as informed consent form (ICF) de-coding for clinical work? Will our
partner scale with our genomics and proteomics needs from research through CAP/CLIA lab services?
Reputation – Is our partner an industry leader for pharmaceutical customer site services with a positive track
record of references?
Leadership from the pharmaceutical company decided to reach out to the sample management community for
guidance and support. The company contracted two service providers for an inventory pilot. The providers were
assessed for contract and quality compliance with support through Informed Consent Form (ICF) annotation.
A global pilot program was established with three primary project goals: (1) establishment of biorepository local cores
at the client sites; (2) creating a unified, global inventory for samples stored in-lab, in the local core, or at Azenta; (3)
executing local deployment of tactics.
Stakeholders from clinical, research, procurement, quality, digital, data, and leadership teams evaluated the results of
these activities and Azenta Life Sciences emerged as the partner of choice.
The sample management and exploration expertise offered by Azenta provided the confidence and security to
implement solutions for the following:
• Rationalization of research and clinical samples to
ensure only samples suitable for use were retained
• Inventory of all human biological and cell line
samples at a sample level to ensure compliance
• Inventory of critical reagents and common use
biologicals for optimization of inventory
• Enabling global visibility and searchability through
unified inventory data terminology
• Establishing a modular approach to sample storage
based on use parameters
• Optimization of storage space resulting in reduced
carbon footprint and operating and capital expensesSample Management and Automation | Case Study
Azenta Life Sciences 4
The Details
ESTABLISHING LOCAL CORES
Client laboratory management established global governance and compliance for samples to ensure an efficient use
of space and budget that suited the urgency of research needs. Azenta provided guidance for narrowing samples into
three storage options that offered the flexibility to meet all these challenges with storage and transportation solutions
in the lab, on-site at a local core, or at Azenta (Figure 1). In-lab samples were defined as those needed daily/weekly for
active projects. The local core would house samples that may require same-day delivery to the lab. All other samples
that were retained were to be sent to Azenta for 24–48-hour delivery to users upon request. Standard operating
procedures (SOPs) were formalized to ensure users working with sample inventory could correctly route them to a final
destination.
CONTINUED RESEARCH DURING SAMPLE MANAGEMENT IMPROVEMENT
Program activities were driven by 4 teams comprised of members from both Azenta and the pharmaceutical company;
Biorepository, Digital, Compliance, and New Sample Acquisition. These 4 teams worked together to ensure the overall
mission of the program was met. The initial activities of the Biorepository team focused on change management.
Scientists were used to keeping their materials (samples, critical reagents, and equipment) in the lab, which had
accumulated over the years. With turnover in staff and limited inventory management, there was some material in the
units that had little to no information associated with them. Decision trees for which materials to retain versus which
to discard were established, along with guidance for how and where to store these materials in the future and the
benefits this would bring to the researchers.
With less than 50% of materials cataloged, the Digital team’s solution consisted of integrating and replacing the
multiple existing inventory systems with a single system as well as digitizing non-inventoried samples. Azenta
assisted the digital team by verifying information for samples already cataloged against the physical sample, ensuring
that any required information available on the material or material storage container was captured using consistent
nomenclature, and recording the exact location of each material. Any materials that were not in an inventory system
USE DAILY/WEEKLY
In the Lab
OPTION A
SAME DAY DELIVERY
At the Local Core
OPTION B
24-48 HR. DELIVERY
At Azenta
OPTION C
Ambient, +4°C,
-20°C, -70°C,
-80°C & LN2
Figure 1. Example of Azenta guidance for sample culling and storageSample Management and Automation | Case Study
Azenta Life Sciences 5
were fully cataloged by Azenta and then linked to critical metadata. This digital process allows client scientists to
access any sample from anywhere in the world.
The Compliance team was a critical partner for ensuring that the materials retained, and data captured against them,
were in line with the human subject regulations and licensing requirements. The New Sample Acquisition team focused
on commercially-acquired sample compliance and efficiency.
These teams worked concurrently to begin the execution of this program in three phases.
PHASE
Q3-Q4 2021
150K samples
30 users
01
PHASE
Q1-Q2 2022
1.5M samples; 50K cell lines
530 users
02
PHASE
Q3-Q4 2022
2.2M samples; 300K cell lines
2500+ users
03
LOCAL CORE SET-UP
• Global governance and
compliance (establish SOPs,
culling samples)
• Pilot core set-up (2 sites)
DIGITAL PLATFORM
• Database set-up for core
• Integration of exisitng
inventories
LOCAL DEPLOYMENT
• Freezer cleaning and
inventory (2 sites)
LOCAL CORE SET-UP
• Local governance and
compliance
• Continued core set-up
DIGITAL PLATFORM
• Continued database set-up
for core and integration of
existing inventories
LOCAL DEPLOYMENT
• Completed deployment at
one site
• Freezer cleaning and
inventory expansion to
remaining 6 sites
• Sample movement to Azenta
biorepositories
LOCAL CORE SET-UP
• Complete local governance
and compliance
• Running activities for cores
DIGITAL PLATFORM
• Advanced search and
analytics implementation
• Continued integration of
existing inventories
• Replacement of legacy
solutions
LOCAL DEPLOYMENT
• Complete freezer cleaning
and inventory
• Final sample movement to
Azenta biorepositoriesSample Management and Automation | Case Study
Azenta Life Sciences 6
LOCAL DEPLOYMENT
To initiate the proposed execution, Azenta equipment and technical teams visited client sites to establish an on-site
presence and enable a close partnership throughout the process. These teams guided users in considerations for
sample culling and storage assignment while also providing automated liquid nitrogen (LN2) freezers for local core
storage. This process of culling, storage prioritization, and laboratory optimization resulted in a 47% reduction of cold
storage units (CSUs) at the customer’s site while still maintaining back-up units and space for surge activity (Figure 2).
Inventory of materials was performed both at the client and Azenta sites depending upon whether scientist support
was needed to help identify the material. Regardless of storage location, all inventory activities were performed
under Azenta SOPs with population of client-required fields. Data wrangling services were also utilized to standardize
variable nomenclature and organize data for loading into the digital solution.
Innovative technologies were implemented in conjunction with the inventory to facilitate the reduction in CSUs. For
example, materials from 51 manual LN2 tanks were consolidated into 13 automated LN2 units provided by Azenta.
With the library control feature on the automated freezers restricting access to individual boxes to only the sample
owners and trained biobank personnel, the scientists gained confidence in the use of shared storage environments for
their most precious biological samples.
New tools were also put into place to allow for more efficient sample management at the bench. Pre-barcoded tubes
and barcode readers were made available to scientists to aid in sample tracking activities and reduce transcription
errors that can be found with manual labeling practices. These tubes were also automation friendly to allow for
efficient downstream uses.
At the time of publishing this study, the 8 original US facilities had successfully relocated to the new building. Material
deliveries from the local core and Azenta long-term storage facility are occurring on a regular basis. In addition,
inventory efforts have begun at two of the client’s facilities in Europe using the same proven methods applied in the
US. In total, Azenta will provide inventory services at 21 locations for the customer in support of this project.
1
Asset inventory
to conrm
number of CSUs
2
Inventory
planning and
prioritization
3
Box-level
inventory
and racking
assessment
4
Assessment
facilitation
5
Sorting, labeling, and
transporting for discard,
short-term storage, or
long-term storage
Figure 2. Process Overview for Reduction of 1400 Cold Storage Units to 740Sample Management and Automation | Case Study
Azenta Life Sciences 7
The Results
Azenta partnered with this multinational biopharmaceutical client to provide a better storage management solution.
Through the rationalization and inventory of the samples using standardized methods and terminology, the client
has full visibility to their biological samples and other materials. This enables sharing of the samples and adheres to
compliance requirements associated with human biological samples and licensed materials.
New tools and processes were put into place to enable ongoing sample management in an efficient manner, reducing
the overall cost of operations and significantly decreasing the carbon footprint associated with cold storage.
The long-term storage materials at Azenta are easily accessible to the scientists. CAP-accredited sample processing
options, such as nucleic acid extraction and automated aliquoting, allow the client to obtain their samples in testready format. Azenta also offers genomic, transcriptomic, and proteomic analysis, maintaining visibility and chain of
custody of the samples.
ANNUAL METRIC TON
REDUCTION IN CO2 EMISSIONS
WITH REDUCTION IN STORAGE
FLEET AND ADDED TRANSPORT
REQUIREMENTS
The transformative impact of this program was recognized internally
by the client as their project team leading the efforts received the
company’s 2022 Global R&D Award.
CONSOLIDATED SITES AND CREATED
CENTRAL INVENTORY
418 HOMES’ ELECTRICITY
USE FOR 1 YEAR
4.979 BARRELS OF OIL
CONSUMED
2,379,394 POUNDS OF
COAL BURNED
241,989 GALLONS OF
GASOLINE CONSUMED
5,338,120 MILES DRIVEN
BY AN AVERAGE GASOLINEPOWERED PASSENGER VEHICLE
EQUIVALENT CO2
EMISSION SAVINGS
REDUCED
PROCUREMENT EFFORTS
CUSTOMER SITE COST OF
OPERATIONS REDUCTION
THROUGH OPERATING
EXPENSE, CAPITAL, AND
SPACE SAVINGS
MOVED TO AZENTA FOR
LONG TERM STORAGE
WITH PLANNED 2-YEAR
EVALUATION CYCLE
IMPROVED LEGAL
AND COMPLIANCE
PROCESSES WITH
INFORMED USAGE
AND TRACEABILITY
REDUCTION IN COLD
STORAGE UNITS AT
CLIENT’S FACILITY
FOR SHORT AND
MEDIUM STORAGE
REQUIREMENTS
Source for CO2e Saving Equivalents: Greenhouse Gas Equivalencies Calculator | US EPASample Management and Automation | Case Study
azenta.com
© 2023 Azenta US, Inc. All rights reserved. All trademarks are property of
Azenta US, Inc. unless otherwise specified. 77004-CS 0423
EXPLORE BETTER MANAGEMENT STORAGE SOLUTIONS →
Conclusion
Streamlining material storage and management poses many unique challenges. Azenta answered these client
challenges with decades of experience, meticulous and thoughtful planning, expansive capabilities, and a
respected reputation. By integrating industry-leading sample capabilities and enterprise-wide sample exploration
and management solutions, Azenta Life Sciences partnered with this client to improve operations and accelerate
therapeutic discovery, development, and delivery. These leading solutions across inventory services, multiomics,
cryogenic storage, automation, and informatics are dedicated to accessing new frontiers in sample exploration and
management to partner with clients bringing impactful breakthroughs and therapies to market with greater speed
and reliability.
Find out how you can minimize risk, improve sample quality, and enhance access for your own valuable samples,
materials, and drug products with a complete better storage management solution for pharmaceutical research from
Azenta Life Sciences.
“AZENTA HAS BEEN AN OUTSTANDING PARTNER IN OUR
TRANSFORMATION JOURNEY. AIMING TO BUILD A HOLISTIC R&DWIDE FRAMEWORK TO MANAGE THE ENTIRE LIFECYCLE OF
OUR BIOLOGICAL SAMPLE COLLECTION IN AN EFFICIENT AND
COMPLIANT MANNER, AZENTA ACCOMPANIES EVERY STEP OF OUR
TRANSFORMATION THROUGH A STRONG AND DIVERSIFIED SET OF
SERVICES, THROUGH THEIR EXPERT KNOWLEDGE AND STATE-OFTHE-ART CAPABILITIES, AND THROUGH THEIR COMMITMENT TO
ADAPT CONSTANTLY TO MEET OUR SPECIFIC REQUIREMENTS AND
DIFFERENT LOCAL NEEDS, ALL IN A TRULY COLLABORATIVE WAY.”
Business Performance Leader, Global R&D
Processes and Operations Leader at this
Biopharmaceutical Company
Brought to you by
Download the Case Study for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Experiencing issues viewing the form? Click here to access an alternate version